Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 727

1.
2.

Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.

Fox CS, Golden SH, Anderson C, Bray GA, Burke LE, de Boer IH, Deedwania P, Eckel RH, Ershow AG, Fradkin J, Inzucchi SE, Kosiborod M, Nelson RG, Patel MJ, Pignone M, Quinn L, Schauer PR, Selvin E, Vafiadis DK; American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health, Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Surgery and Anesthesia, Council on Quality of Care and Outcomes Research, and the American Diabetes Association.

Diabetes Care. 2015 Sep;38(9):1777-803. doi: 10.2337/dci15-0012. Epub 2015 Aug 5. Review.

PMID:
26246459
3.

Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.

Fox CS, Golden SH, Anderson C, Bray GA, Burke LE, de Boer IH, Deedwania P, Eckel RH, Ershow AG, Fradkin J, Inzucchi SE, Kosiborod M, Nelson RG, Patel MJ, Pignone M, Quinn L, Schauer PR, Selvin E, Vafiadis DK; American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health, Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Surgery and Anesthesia, Council on Quality of Care and Outcomes Research, and the American Diabetes Association.

Circulation. 2015 Aug 25;132(8):691-718. doi: 10.1161/CIR.0000000000000230. Epub 2015 Aug 5.

PMID:
26246173
4.

[GLP-1 receptor agonists versus SGLT-2 inhibitors in obese type 2 diabetes patients].

Marques AR, Jaafar J, de Kalbermatten B, Philippe J.

Rev Med Suisse. 2015 Jun 3;11(477):1227-8, 1230-3. Review. French.

PMID:
26211282
5.

[Metformin: new data for an old molecule].

Sanduloviciu M, Jornayvaz FR.

Rev Med Suisse. 2015 Jun 3;11(477):1222-6. Review. French.

PMID:
26211281
6.

Overcoming Clinical Inertia: A Randomized Clinical Trial of a Telehealth Remote Monitoring Intervention Using Paired Glucose Testing in Adults With Type 2 Diabetes.

Greenwood DA, Blozis SA, Young HM, Nesbitt TS, Quinn CC.

J Med Internet Res. 2015 Jul 21;17(7):e178. doi: 10.2196/jmir.4112.

7.
8.

Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis.

Fu H, Cao D, Boye KS, Curtis B, Schuster DL, Kendall DM, Ascher-Svanum H.

Diabetes Ther. 2015 Jul 5. [Epub ahead of print]

PMID:
26142890
9.

Update on strategies limiting iatrogenic hypoglycemia.

Bonaventura A, Montecucco F, Dallegri F.

Endocr Connect. 2015 Sep;4(3):R37-45. doi: 10.1530/EC-15-0044. Epub 2015 Jun 22. Review.

10.

Fifty-two-week long-term clinical study of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus inadequately controlled with diet and exercise.

Seino Y, Kaku K, Inagaki N, Haneda M, Sasaki T, Fukatsu A, Ubukata M, Sakai S, Samukawa Y.

Endocr J. 2015 Jul 31;62(7):593-603. doi: 10.1507/endocrj.EJ15-0097. Epub 2015 May 12.

11.

The Current Drug Treatment Landscape for Diabetes and Perspectives for the Future.

Bailey CJ.

Clin Pharmacol Ther. 2015 Aug;98(2):170-84. doi: 10.1002/cpt.144. Epub 2015 Jun 23.

PMID:
25963904
12.

Continual evolution of type 2 diabetes: an update on pathophysiology and emerging treatment options.

Cornell S.

Ther Clin Risk Manag. 2015 Apr 16;11:621-32. doi: 10.2147/TCRM.S67387. eCollection 2015. Review.

13.

Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: insights from the Associazione Medici Diabetologi Annals initiative.

De Cosmo S, Viazzi F, Pacilli A, Giorda C, Ceriello A, Gentile S, Russo G, Rossi MC, Nicolucci A, Guida P, Di Bartolo P, Pontremoli R; AMD-Annals Study Group.

Nephrol Dial Transplant. 2015 Sep;30(9):1526-33. doi: 10.1093/ndt/gfv101. Epub 2015 Apr 16.

14.

High hydrostatic pressure processing reduces the glycemic index of fresh mango puree in healthy subjects.

Elizondo-Montemayor L, Hernández-Brenes C, Ramos-Parra PA, Moreno-Sánchez D, Nieblas B, Rosas-Pérez AM, Lamadrid-Zertuche AC.

Food Funct. 2015 Apr;6(4):1352-60. doi: 10.1039/c4fo01005a.

PMID:
25797308
15.

ISFM consensus guidelines on the practical management of diabetes mellitus in cats.

Sparkes AH, Cannon M, Church D, Fleeman L, Harvey A, Hoenig M, Peterson ME, Reusch CE, Taylor S, Rosenberg D; ISFM.

J Feline Med Surg. 2015 Mar;17(3):235-50. doi: 10.1177/1098612X15571880.

PMID:
25701862
16.

Dulaglutide: an evidence-based review of its potential in the treatment of type 2 diabetes.

Edwards KL, Minze MG.

Core Evid. 2015 Jan 9;10:11-21. doi: 10.2147/CE.S55944. eCollection 2015. Review.

17.

Gestational diabetes mellitus: Where are we now?

Ashwal E, Hod M.

Clin Chim Acta. 2015 Feb 2. pii: S0009-8981(15)00043-1. doi: 10.1016/j.cca.2015.01.021. [Epub ahead of print]

PMID:
25655741
18.

[Dapagliflozin: Beyond glycemic control in the treatment of type 2 diabetes mellitus].

Sanz-Serra P, Pedro-Botet J, Flores-Le Roux JA, Benaiges D, Chillarón JJ.

Clin Investig Arterioscler. 2015 Jul-Aug;27(4):205-11. doi: 10.1016/j.arteri.2014.11.001. Epub 2015 Jan 31. Spanish.

PMID:
25648671
19.

[Cardiovascular risk reduction in the management of diabetic patients: what has changed since the '90s in the clinical approach?].

Consoli A, Di Fulvio P.

G Ital Cardiol (Rome). 2014 Dec;15(12 Suppl 2):21S-26S. doi: 10.1714/1762.19114. Italian.

PMID:
25623547
20.

Estimating Cost-Effectiveness in Type 2 Diabetes: The Impact of Treatment Guidelines and Therapy Duration.

McEwan P, Gordon J, Evans M, Ward T, Bennett H, Bergenheim K.

Med Decis Making. 2015 Jul;35(5):660-70. doi: 10.1177/0272989X14565821. Epub 2015 Jan 16.

PMID:
25596535
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk